Bamlanivimab as monotherapy in two immunocompromised patients with COVID-192명의 면역저하 코로나19 환자에서 단독요법으로 밤라니비맙(Bamlanivimab) Published on 2021-09-012022-09-12 Journal: The Lancet. Microbe [키워드] bamlanivimab Immunocompromised patient monotherapy with COVID-19 [저자] Grégory Destras, Souad Assaad, Antonin Bal, Maude Bouscambert-Duchamp, Virginie Avrillon, Bruno Simon, Martine Valette, Jean-Yves Blay, Bruno Lina, Emilie Frobert, Laurence Josset [Category] Fulltext, SARS, 진단, PMC URL [DOI] 10.1016/S2666-5247(21)00189-0 [Article Type] Article [Source] PMC All Keywords 【제목키워드】 bamlanivimab, Immunocompromised patient, monotherapy, with COVID-19,